A Study of BGM-2121 in Patients With Advanced Solid Tumors

NCT07346846 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: BGM-2121

Sponsor

BioGate Precision Medicine Corp.